Lilly Shares Jump On 7.9% Weight Loss Pill Eli Lilly said on Thursday its experimental pill, orforglipron, led to weight loss of nearly 8% at the highest dose and lowered blood sugar in patients with type 2 diabetes in a late-stage trial. By ryounglao|2025-04-17T10:33:19-04:00April 17, 2025|International News|0 Comments Share This Story, Choose Your Platform! FacebookXRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: ryounglao Related Posts Global Stocks Hit Longest Losing Run Since 2023 Global Stocks Hit Longest Losing Run Since 2023 Oil Prices Set For Third Straight Weekly Decline On Strong Middle East Export Flows Oil Prices Set For Third Straight Weekly Decline On Strong Middle East Export Flows Anthropic Slumps 5% Post-Market After Record $107.3 Billion IPO Anthropic Slumps 5% Post-Market After Record $107.3 Billion IPO SpaceX Sells $32 Billion Of AI Chip Debt At Yields Topping 8% SpaceX Sells $32 Billion Of AI Chip Debt At Yields Topping 8% Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment. Δ
Leave A Comment